Pronađeno: 1-9 / 9 radova

Autori: Tiede Andreas

>> Filter: Samo Article i Review

Naslov Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A (Article)
Autori Tiede Andreas  Rosa Cid Ana  Goldmann Georg  Jimenez-Yuste Victor  Pluta Michael  Lissitchkov Toshko  May Marcus  Matytsina Irina  Miljic Predrag S  Pabinger Ingrid  Persson Paula 
Info THROMBOSIS AND HAEMOSTASIS, (2020), vol. 120 br. 2, str. 277-288
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)Novo Nordisk
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A (Meeting Abstract)
Autori Tiede Andreas  Goldmann Georg  Miljic Predrag S  Korsholm Lars  Matytsina Irina  Persson Paula  Jelev Lissitchkov Toshko 
Info BLOOD, (2018), vol. 132 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article)
Autori Lentz Steven R  Janic Dragana M  Kavakli Kaan  Miljic Predrag S  Oldenburg Johannes  Ozelo Margareth Castro  Santagostino Elena  Suzuki Takashi  Zupancic-Salek Silva  Korsholm Lars  Matytsina Irina  Tiede Andreas 
Info HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394
Projekat Novo Nordisk A/S
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas  Janic Dragana M  Ozelo M  Santagostino E  Korsholm Lars  Matytsina Irina  Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter)
Autori Lentz SR  Cerqueira MH  Janic Dragana M  Kempton CL  Matytsina Irina  Misgav M  Oldenburg J  Ozelo M  Recht M  Rosholm A  Savic Aleksandar D  Suzuki Takashi  Tiede Andreas  Santagostino E 
Info HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial (Meeting Abstract)
Autori Janic Dragana M  Karim Faraizah Abdul  Matytsina Irina  Ozelo Margareth Castro  Savic Aleksandar D  Tiede Andreas  Oldenburg Johannes 
Info HAEMOPHILIA, (2016), vol. 22 br. , Suppl. 4, str. 48-48
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR  Kempton CL  Janic Dragana M  Savic Aleksandar D  Cerqueira MH  Ozelo MC  Recht M  Oldenburg J  Tiede Andreas  Suzuki Takashi  Matytsina Irina  Zeuthen N  Santagostino E 
Info JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2015), vol. 13 br. , Suppl. 2, str. 842-842
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article)
Autori Lentz SR  Misgav M  Ozelo MC  Salek SZ  Veljkovic Dobrila K  Recht M  Cerqueira MH  Tiede Andreas  Brand B  Mancuso ME  Seremetis S  Lindblom A  Martinowitz U 
Info HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR  Misgav M  Ozelo MC  Zupancic-Salek Silva  Veljkovic Dobrila K  Recht M  Cerqueira MH  Tiede Andreas  Brand B  Mancuso ME  Martinowitz U 
Info HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-830
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX